[Action of a polyene macrolide on hyperdyslipidemic disorders]

Related Experiment Video

Updated: Aug 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Barbaro, G Casella

    Archivio Per Le Scienze Mediche
    |April 1, 1980
    PubMed

    Insights

    Mepartricin significantly reduced lipid levels in patients with primary hyperlipemia. This cholesterol-lowering effect persisted 30 days after treatment completion, indicating sustained efficacy.

    Area of Science:

    • Pharmacology
    • Lipid Metabolism
    • Gastroenterology

    Context:

    • Primary hyperlipemia is a condition characterized by elevated lipid levels.
    • Cholesterol absorption plays a key role in hyperlipidemia.
    • Developing effective treatments for hyperlipidemia is crucial.

    Purpose:

    • To evaluate the efficacy and tolerance of mepartricin, a polyene macrolide.
    • To assess mepartricin's impact on intestinal cholesterol absorption.
    • To determine the effect of mepartricin on lipid values in hyperlipemic patients.

    Summary:

    • Mepartricin (SPA-S-160) was administered to 50 patients with primary hyperlipemia at a dosage of 3 tablets daily for 30 days.
    • Significant reductions in lipid values (P < 0.01) were observed during and after the treatment period.
    • Lipid levels remained lower than baseline 30 days post-treatment, suggesting sustained cholesterol-lowering effects.

    Impact:

    • Mepartricin demonstrates significant efficacy in managing primary hyperlipemia.
    • The drug exhibits a favorable tolerance profile.
    • Sustained lipid reduction post-treatment highlights mepartricin's therapeutic potential.

    More Related Videos

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

    Published on: November 17, 2018

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia11:06

    Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

    Published on: April 7, 2023

    Related Concept Videos

    Receptor-mediated Endocytosis01:38

    Receptor-mediated Endocytosis

    Overview
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Antiasthma Drugs: Leukotriene Modifiers01:19

    Antiasthma Drugs: Leukotriene Modifiers

    Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
    Leukotriene modifiers work through two distinct mechanisms:
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...